Kardigan, Inc.
NASDAQ:KARDBiotechnology
Healthcare
$12.32 +3.50%
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
52W Low $16.25High $24.00
Volume 0.55M
Average 5.84M
KARD EBITDA Margin
EBITDA as a percentage of revenue.
No reported EBITDA Margin figures are available to summarize.
EBITDA Margin history
Percent of revenue · from the income statement
No EBITDA Margin data reported for this period type.
EBITDA Margin vs competitors
How KARD compares with its peers on the latest reported figures
KARD Competitors Peer median
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| FY2025 | -410.9% | — | — | |
| LTM Jun 2026 | -1158.1% | -569.3 pp | -529.1 pp | |
| LTM Jun 2026 | -3579.7% | -3279.2 pp | -1055.1 pp | |
| LTM Mar 2026 | -33540.9% | — | — | |
| — | — | — | — | |
| FY2025 | — | — | — | |
| Peer median (excluding KARD) | -2368.9% | -1924.2 pp | -792.1 pp | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Currency unavailable
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.